Natco Pharma, operating in the Pharmaceuticals sector and classified as a Smallcap on the BSE, currently has its share price at ₹826.85. The stock has experienced fluctuations today, with a low ...

NATCO Pharma Share Price: NATCO Pharma shares on Thursday crashed 20 per cent to hit the lower circuit after poor Q3 results FY2025. NATCO Pharma shared opened gap down with a cur of nearly 14 per ...

Stock Market Today: Natco Pharma share price gained more than 7% to scale 52-week highs on Thursday, The Natco Pharma share price has gained more than 90% year to date. The strong performance in ...

Natco Pharma on Tuesday shared a legal ... ratio of 7.87 against a price-to-book (P/B) value of 2.04. Earnings per share (EPS) stood at 98.90 with a return on equity (RoE) of 25.89.

<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b ...

Nifty Pharma has fallen by 12.8 per cent so far this year, with Natco Pharma and Granules India leading the plunge ...

Natco Pharma has decided to price Risdiplam, indicated for the treatment of rare genetic disorder Spinal Muscular Atrophy (SMA), at₹15,900. In an update on the legal proceedings on the ...

The drug enhances the flow of blood through the lungs, allowing children with PAH to breathe and improve their ability to engage in physical activity.

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

Natco Pharma Limited is a vertically ... of 1 crore Equity Shares at the issue price of Rs 915 per Equity (including a premium of Rs. 913 per Equity Share) upon the closure of the issue, to ...